|
|
The Key
to Improving Immunotherapy
A recent diabetes-related discovery
by CRI Lloyd J. Old STAR Dr. Andrea Schietinger of Memorial Sloan Kettering
Cancer Center has promising implications for cancer immunotherapy. In this
interview she discusses how autoimmunity in type 1 diabetes is yielding new
insights for how to keep our T cells from becoming exhausted as they try to
attack tumors. |
Thursday, September 8, 2022
THE KEY TO IMPROVING IMMUNOTHERAPY
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment